Vanda Pharmaceuticals (VNDA)
4.05
+0.04 (1.00%)
Upcoming Events
Latest Headlines
Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
October 21, 2026 5:40 PM - PR NewsWire
Vanda Pharmaceuticals' anxiety drug fails Phase III trial
October 14, 2026 5:00 PM - StreetInsider
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
October 14, 2026 5:00 PM - PR NewsWire
Form SCHEDULE 13G/A Vanda Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC
October 9, 2026 5:26 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
October 5, 2026 6:50 AM - StreetInsider
Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting
October 2, 2026 9:06 AM - PR NewsWire
Vanda reports positive Phase III results for HETLIOZ in sleep disorder
September 29, 2026 7:10 PM - StreetInsider
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
September 29, 2026 6:45 PM - PR NewsWire
Oppenheimer Starts Vanda Pharmaceuticals (VNDA) at Outperform
September 23, 2026 6:06 AM - StreetInsider
EU grants Vanda's imsidolimab first orphan status for rare skin disease
August 24, 2026 7:04 AM - StreetInsider
Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
August 24, 2026 7:00 AM - PR NewsWire
NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
August 22, 2026 3:17 PM - PR NewsWire
Form SCHEDULE 13G Vanda Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC
August 19, 2026 6:32 PM - SEC Filing
This biotech stock offers a buying opportunity: B. Riley
August 15, 2026 10:00 AM - StreetInsider
Form SCHEDULE 13G Vanda Pharmaceuticals Filed by: AQR CAPITAL MANAGEMENT LLC
August 13, 2026 9:23 AM - SEC Filing
Vanda Pharmaceuticals (VNDA) PT Lowered to $12 at B.Riley
August 10, 2026 8:18 AM - StreetInsider
Vanda Pharmaceuticals (VNDA) PT Lowered to $20 at H.C. Wainwright
August 10, 2026 6:49 AM - StreetInsider
Form 10-Q Vanda Pharmaceuticals For: Jun 30
August 6, 2026 7:39 AM - SEC Filing
Vanda Pharmaceuticals (VNDA) Misses Q2 EPS by 44c; Offers Guidance
August 5, 2026 4:05 PM - StreetInsider
Form 8-K Vanda Pharmaceuticals For: Aug 05
August 5, 2026 4:05 PM - SEC Filing
Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 5, 2026 4:01 PM - PR NewsWire
Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 29, 2026 4:32 PM - PR NewsWire
Full Article List
